Negative regulation of binding

pathway activity — cross-omics
GO:0051100Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of binding pathway is significantly associated with the protein abundance of multiple proteins, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are CEP170, NID2, and YME1L1, each associated with the pathway in up to 8 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of binding activity versus CEP170 in BRCA (Pearson r = 0.31).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCACEP170 →+0.301+0.032<.001<.00137
BRCANID2 →+0.331+0.022.008<.00137
UCECYME1L1 →-0.385-0.040.002.00137
CCRCCMMP2 →+0.395+0.024.002.00228
BRCARCN3 →+0.375+0.031.009<.00136
GBMSAMHD1 →+0.389+0.039<.001<.00136
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0051100 vs CEP170 — BRCA

Per-sample scatter of Negative regulation of binding activity vs CEP170 in BRCA.

Explore this scatter interactively →

Exploration